The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.
2006
DOI: 10.1177/0960327106070671
|View full text |Cite
|
Sign up to set email alerts
|

Arsenic-induced toxicity: effect on protein composition in sciatic nerve

Abstract: Exposure to arsenic compounds may lead to skin and lung cancer and various disorders such as vascular disease and peripheral neuropathy in humans. Peripheral arsenic neurotoxicity has been demonstrated clinically and in electrophysiological studies. Patients intoxicated with arsenic show neurological symptoms in their feet and hands. These patients show significantly lower nerve conduction velocities (NCVs) in their peripheral nerves in comparison with controls. The mechanism of arsenic peripheral ner… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
21
0

Year Published

2009
2009
2021
2021

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 46 publications
(24 citation statements)
references
References 23 publications
3
21
0
Order By: Relevance
“…injected in a tail vein, Vahidnia et al, 2006) and a 4-12 week repeated daily administration (3, 10 mg/kg b.w., intragastric route, Vahidnia et al, 2008a), whereas in vitro neither arsenite nor arsenate (0.3-3 µM, 24 or 48 hours incubation) changed NF-L gene expression (Vahidnia et al, EFSA Journal 2009;7 (10):1351 2007b). However, in vitro trivalent inorganic arsenic increased intracellular calcium (Florea et al, 2007), which is most probably responsible for p35 proteolytic cleavage to p25 by calpain resulting in hyperphosphorylation of cytoskeletal proteins including MAP-tau (Vahidnia et al, 2008b).…”
Section: Inorganic Arsenicmentioning
confidence: 99%
“…injected in a tail vein, Vahidnia et al, 2006) and a 4-12 week repeated daily administration (3, 10 mg/kg b.w., intragastric route, Vahidnia et al, 2008a), whereas in vitro neither arsenite nor arsenate (0.3-3 µM, 24 or 48 hours incubation) changed NF-L gene expression (Vahidnia et al, EFSA Journal 2009;7 (10):1351 2007b). However, in vitro trivalent inorganic arsenic increased intracellular calcium (Florea et al, 2007), which is most probably responsible for p35 proteolytic cleavage to p25 by calpain resulting in hyperphosphorylation of cytoskeletal proteins including MAP-tau (Vahidnia et al, 2008b).…”
Section: Inorganic Arsenicmentioning
confidence: 99%
“…On the other hand, As-induced degeneration of axon structure may also be the contributor for delaying brain development. Obvious decline of the neurofilament light chain in sciatic nerve is found in As-treated rats, and this contributed to degeneration of the nervous integrity (Vahidnia et al 2006). Besides, As intoxication gave rise to reduction of nerve conduction velocity and might involve axonal degeneration (Goebel et al 1990).…”
Section: Introductionmentioning
confidence: 99%
“…Wistar rats to arsenic caused a dose-dependent decrease in neurofilament M and L proteins in the sciatic nerve [113]. These components are required for the formation of a heteropolymer in the cytoskeleton.…”
Section: Neurofilaments and Microtubules In Vivo Exposure Ofmentioning
confidence: 99%
“…Neurotransmitter release was possibly affected through interaction with many of the targets above as well as through interaction with synthesis and degradation of neurotransmitters and enzymes in the metabolic pathway, which resulted in modulation of neurotransmitter release by metals such as copper, manganese, and tin [101][102][103]. The mRNA expression of neurofilaments was affected by arsenic [113]. Often contradictory results were obtained regarding the effects of metals, which may indicate that metals had different effects on targets depending on the state of the metal, its concentration, the medium, the area of the brain, and whether the experiment was in vivo or in vitro.…”
Section: Neurofilaments and Microtubules In Vivo Exposure Ofmentioning
confidence: 99%